Table 2.
Biochemical comparison between NASH-HCC and ASH-HCC groups
| Variable | Etiology |
P-value | |
|---|---|---|---|
| NASH-HCC (n=54) | ASH-HCC (n=45) | ||
| Age | 72±9 | 66±9 | <0.001 |
| BMI (kg/m2) | 27.2±4.6 | 23.7±5.0 | 0.08 |
| Albumin (g/L) | 29±8 | 30±5 | 0.29 |
| Bilirubin (umol/L) | 44±59 | 47±63 | 0.11 |
| ALP (IU/L) | 143±91 | 169±124 | 0.45 |
| ALT (IU/L) | 40±21 | 41±23 | 0.88 |
| AST (IU/L) | 91±109 | 73±50 | 0.96 |
| GGT (IU/L) | 73±135 | 179±273 | 0.06 |
| AFP (ug/L) | 8,241±19,343 | 21,633±107,187 | 0.41 |
| CTP score | 7.67±1.95 | 7.73±1.97 | 0.98 |
| MELD | 12.55±5.1 | 13.29±4.9 | 0.48 |
Values are presented as mean±standard deviation.
NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma; ASH, alcoholic steatohepatitis; BMI, body mass index; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; GGT, gamma glutamyl transferases; AFP, alpha-fetoprotein; CTP, Child-Turcotte-Pugh; MELD, model for end-stage liver disease.